235 related articles for article (PubMed ID: 15975027)
1. Amyloid associated proteins in Alzheimer's and prion disease.
Veerhuis R; Boshuizen RS; Familian A
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation in Alzheimer's disease and prion disease.
Eikelenboom P; Bate C; Van Gool WA; Hoozemans JJM; Rozemuller JM; Veerhuis R; Williams A
Glia; 2002 Nov; 40(2):232-239. PubMed ID: 12379910
[TBL] [Abstract][Full Text] [Related]
3. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q.
Veerhuis R; Boshuizen RS; Morbin M; Mazzoleni G; Hoozemans JJ; Langedijk JP; Tagliavini F; Langeveld JP; Eikelenboom P
Neurobiol Dis; 2005; 19(1-2):273-82. PubMed ID: 15837583
[TBL] [Abstract][Full Text] [Related]
4. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
6. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
Li B
Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
[TBL] [Abstract][Full Text] [Related]
8. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
9. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides.
Forloni G; Tagliavini F; Bugiani O; Salmona M
Prog Neurobiol; 1996 Jul; 49(4):287-315. PubMed ID: 8888112
[TBL] [Abstract][Full Text] [Related]
10. Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation.
White AR; Maher F; Brazier MW; Jobling MF; Thyer J; Stewart LR; Thompson A; Gibson R; Masters CL; Multhaup G; Beyreuther K; Barrow CJ; Collins SJ; Cappai R
Brain Res; 2003 Mar; 966(2):231-44. PubMed ID: 12618346
[TBL] [Abstract][Full Text] [Related]
11. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.
Rozemuller AJ; van Gool WA; Eikelenboom P
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):223-33. PubMed ID: 15975026
[TBL] [Abstract][Full Text] [Related]
12. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
Chiarini A; Dal Pra I; Whitfield JF; Armato U
Ital J Anat Embryol; 2006; 111(4):221-46. PubMed ID: 17385278
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer's Disease (AD) and Prion Disease (PrD).
Lukiw WJ
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204666
[TBL] [Abstract][Full Text] [Related]
14. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
15. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.
Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ
Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730
[TBL] [Abstract][Full Text] [Related]
17. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
[TBL] [Abstract][Full Text] [Related]
18. Membrane pathology and microglial activation of mice expressing membrane anchored or membrane released forms of Aβ and mutated human Alzheimer's precursor protein (APP).
Jeffrey M; McGovern G; Barron R; Baumann F
Neuropathol Appl Neurobiol; 2015 Jun; 41(4):458-70. PubMed ID: 25131655
[TBL] [Abstract][Full Text] [Related]
19. Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.
Roettger Y; Zerr I; Dodel R; Bach JP
PLoS One; 2013; 8(6):e67743. PubMed ID: 23840767
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
Carroll JA; Chesebro B
Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]